- Tilray Brands reported adjusted EBITDA of $9.04 million for Q3, marking an 11% decrease from the previous year, missing the estimated $9.86 million.
- Net revenue fell by 1.4% year-over-year to $185.8 million, below the estimate of $210.9 million.
- Cannabis revenue dropped 14% year-over-year to $54.3 million, missing the forecast of $65.7 million.
- Distribution revenue showed an increase of 8.3% from the previous year, reaching $61.5 million, but fell short of the $63.1 million estimate.
- Beverage Alcohol revenue increased by 2.3% year-over-year to $55.9 million, below the expected $63.8 million.
- Wellness revenue rose 5% from the previous year to $14.1 million, slightly under the projection of $14.5 million.
- Tilray recorded negative free cash flow of $20.0 million, which is a 17% improvement year-over-year.
- Cash and cash equivalents reached $200.0 million, a robust 37% increase year-over-year, surpassing the estimate of $143.9 million.
- The company adjusted its fiscal year 2025 guidance for net revenue to a range between $850 million and $900 million.
- Tilray’s shares rose 4.8% in pre-market trading, reaching 60.69 cents with a volume of 50,097 shares traded.
A look at Tilray Inc Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 1 | |
| Growth | 2 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Tilray Inc, a pharmaceutical company known for its development of cannabis-based medicines, drugs, drops, and oil products, has received varying Smart Scores across different key factors. While the company has been rated highly in terms of its value with a score of 5, indicating strong fundamentals and potential for long-term growth, Tilray falls short in the dividend category with a score of 1, meaning it may not be a top choice for income-seeking investors.
Looking ahead, Tilray’s overall outlook is somewhat tempered by its growth, resilience, and momentum scores, which range from 2 to 3. This suggests that the company may face challenges in terms of growth opportunities, ability to withstand market fluctuations, and maintaining consistent positive stock performance. Investors may find value in analyzing these Smart Scores to make informed decisions when considering Tilray Inc as a potential long-term investment option.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
